ORS § 689.645

Current through 2024 Regular Session legislation effective April 17, 2024
Section 689.645 - Vaccines, patient care services, drugs and devices; formulary; rules
(1) In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205:
(a) A pharmacist, or a pharmacy technician under the supervision of a pharmacist, may administer vaccines:
(A) To persons who are seven years of age or older;
(B) If authorized by the Governor or the Director of the Oregon Department of Emergency Management under ORS 433.441 or the Public Health Director under ORS 433.443 or 433.444, to a person three years of age or older; or
(C) To persons who are six months of age or older if the vaccine administered is an influenza vaccine.
(b) A pharmacist may, pursuant to a statewide drug therapy management protocol developed by the Public Health and Pharmacy Formulary Advisory Committee convened under ORS 689.649 and adopted by rule of the board, provide approved patient care services including smoking cessation therapy and travel health services.
(c) A pharmacist may, using a form prescribed by the board, submit a concept for the development of a protocol, other than the protocols pharmacists may establish under subsection (5) of this section, to the committee for consideration by the committee and recommendation to the board for adoption by rule of the board.
(d) A pharmacist may prescribe and dispense a drug or device included on the formulary established under subsection (6) of this section if the prescription and dispensation is pursuant to a diagnosis by a health care practitioner who has prescriptive authority and is qualified to make the diagnosis.
(2) The board may adopt rules allowing a pharmacist to prescribe vaccines, provide patient care services and submit protocol concepts under subsection (1) of this section. The rules related to the prescription of vaccines may be only as broad as necessary to enable pharmacists to enroll and participate in the Vaccines for Children Program administered by the Centers for Disease Control and Prevention.
(3) The board is authorized to issue, to pharmacists and pharmacy technicians who have completed training accredited by the Centers for Disease Control and Prevention, the Accreditation Council for Pharmacy Education or a similar health authority or professional body, certificates of special competency in the prescription or administration of vaccines.
(4) The board shall adopt rules relating to the reporting of the prescription and administration of vaccines to a patient's primary health care provider and to the Oregon Health Authority.
(5) The board shall adopt rules requiring pharmacists to establish protocols for the prescription and administration of vaccines and the provision of patient care services under subsection (1) of this section.
(6)
(a) The board shall establish by rule a formulary of drugs and devices, as recommended by the committee, that a pharmacist may prescribe and dispense to a patient pursuant to a diagnosis by a health care practitioner who has prescriptive authority and who is qualified to make the diagnosis.
(b) The formulary may include post-diagnostic drugs and devices such as diabetic testing supplies, emergency refills of insulin, albuterol inhalers, epinephrine autoinjectors, smoking cessation aids, discharge medications for transitions of care, rapid strep tests and spacers.

ORS 689.645

Amended by 2023 Ch. 306, § 1, eff. 7/18/2023, op. 1/1/2024.
Amended by 2023 Ch. 240,§ 1, eff. 9/24/2023, op. 1/1/2024.
Amended by 2017 Ch. 106, § 1, eff. 5/18/2017, op. 1/1/2018.
Amended by 2015 Ch. 362, § 4, eff. 6/11/2015, op. 1/1/2016.
Amended by 2015 Ch. 295, § 1, eff. 6/8/2015, op. 1/1/2016.
Amended by 2013 Ch. 332, § 5, eff. 1/1/2014.
1999 c.350 §3b; 2005 c. 312, § 1; 2009 c. 250, § 1; 2009 c. 595, § 1104; 2011 c. 245, § 1

Section 3, chapter 106, Oregon Laws 2017, provides:

Sec. 3. The name of the Public Health Advisory Committee is changed to the Public Health and Pharmacy Formulary Advisory Committee. The Public Health and Pharmacy Formulary Advisory Committee is a continuation of the Public Health Advisory Committee. [2017 c. 106, § 3]